COVID-19
A multicentric matched case-control study conducted across 47 tertiary care hospitals in 19 states and Union Territories between May and August 2023 has found that COVID-19 vaccination is not associated with unexplained sudden deaths among young adults in India. The study, titled "Factors associated with unexplained sudden deaths among
COVID-19
New research has shed light on the prevalence and risk factors associated with Long COVID, a condition that affects older adults with COVID-19. A recent study published in The Journals of Gerontology: Series A has identified a significant correlation between the number of COVID-19 vaccine doses and the incidence of
COVID-19
The American Medical Association (AMA) has released its AMA Update, covering a range of health care topics that impact the lives of physicians, residents, medical students, and patients. The series features expert speakers addressing critical issues, including COVID-19, medical education, advocacy, burnout, vaccines, and the use of artificial intelligence (AI)
COVID-19
The COVID-19 pandemic has accelerated the need to monitor the risk of SARS-CoV-2 infection and mortality in cancer patients, who are often immunocompromised due to their underlying health conditions and cancer therapies. Researchers from Cedars Sinai Medical Center, in collaboration with the National Cancer Institute and the National Institute of
COVID-19
A religious discrimination lawsuit brought by an employee against defense contractor Aero Simulation, Inc. (ASI) has been dismissed by the Eighth U.S. Circuit Court of Appeals. The plaintiff, Matthew Kale, had objected to ASI's COVID-19 vaccination policy, citing his sincerely held religious beliefs. However, the court found
COVID-19
Researchers from Imperial College London conducted a human infection challenge to characterize the immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in seronegative adults. The study yielded significant findings on the importance of interferon-dominated mediator response, T cell activation, and mucosal and systemic antibodies in viral control. Key
COVID-19
Researchers in Turkey have investigated the potential side effects of the Pfizer-BioNTech COVID-19 vaccine on eye health, finding measurable changes in corneal health, including a slight thickening of the cornea and a decrease in endothelial cell count. These changes were not accompanied by noticeable vision loss, but they may indicate
COVID-19
Research conducted at Ashoka University has shed light on the role of bats as reservoirs for coronaviruses, including SARS-CoV-2, and the impact of climate change on their populations. A high-quality hybrid genome assembly of the Blyth's horseshoe bat, Rhinolophus lepidus, was analyzed to understand the susceptibility to SARS-CoV-2
COVID-19
A national study, led by researchers from the University of Delaware and George Mason University, has revealed significant disparities in healthcare access for adults with disabilities during the COVID-19 pandemic. The study, published in the American Journal of Preventive Medicine, analyzed data from over 150,000 U.S. adults between
COVID-19
During the COVID-19 pandemic, the German government faced significant challenges in allocating limited medical resources. Researchers from the Hannover Medical School in Germany have investigated the ethical dilemmas that arose during this time and proposed solutions to mitigate the discriminatory effects of the utilitarian probability to survive principle. This principle,
COVID-19
The COVID-19 pandemic caused significant disruptions to non-COVID-19 vaccinations in the United States, with a notable decline in vaccination rates among children and adults. Research conducted by the University of Kentucky found that the number of vaccinated individuals decreased by 9.6% among children and adolescents and 4.2% among
COVID-19
Researchers at the Schulich School of Medicine and Dentistry have made significant discoveries regarding the potential use of a synthetic host defense peptide, D-3006, in treating SARS-CoV-2 and other respiratory viral infections. According to a study published in Antimicrobial Agents and Chemotherapy, D-3006 demonstrated broad-spectrum antiviral activity, effectively inhibiting SARS-CoV-2
